Oxford races to trial Bundibugyo Ebola vaccine within months

Oxford researchers are developing an experimental Bundibugyo Ebola vaccine using the ChAdOx1 platform that could enter human trials in two to three months, depending on animal data; the DR Congo outbreak has heightened urgency and the vaccine would be used in ring vaccination, with Serum Institute of India lined up to mass-produce if successful.